![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Klar Neil
Publisher: Taylor & Francis Ltd
ISSN: 1054-3406
Source: Journal of Biopharmaceutical Statistics, Vol.16, Iss.2, 2006-03, pp. : 269-271
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Bender Ralf Skipka Guido Grouven Ulrich
Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 2, 2006-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Surrogate Efficacy Endpoints in Oncology Trials
Pharmaceutical Medicine, Vol. 23, Iss. 5-6, 2009-10 ,pp. :